Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives
E Scott, D Learoyd, RJ Clifton-Bligh - Future oncology, 2016 - Taylor & Francis
The treatment of papillary thyroid cancer is now based on individual patient risk and
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives
E Scott, D Learoyd, RJ Clifton-Bligh - Future Oncology, 2016 - cir.nii.ac.jp
抄録< jats: p> The treatment of papillary thyroid cancer is now based on individual patient
risk and response to therapies. Molecular techniques are increasingly being used to risk …
risk and response to therapies. Molecular techniques are increasingly being used to risk …
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives
E Scott, D Learoyd, RJ Clifton-Bligh - Future Oncology, 2016 - search.proquest.com
The treatment of papillary thyroid cancer is now based on individual patient risk and
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives
E Scott, D Learoyd… - Future oncology …, 2016 - pubmed.ncbi.nlm.nih.gov
The treatment of papillary thyroid cancer is now based on individual patient risk and
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
Therapeutic options in papillary thyroid carcinoma: current guidelines and future perspectives.
E Scott, D Learoyd, RJ Clifton-Bligh - Future Oncology (London …, 2016 - europepmc.org
The treatment of papillary thyroid cancer is now based on individual patient risk and
response to therapies. Molecular techniques are increasingly being used to risk stratify and …
response to therapies. Molecular techniques are increasingly being used to risk stratify and …